hypromellose 0.3%

DRUG2 trials

Sponsors

Allergan

Conditions

GlaucomaOcular Hypertension

Phase 4

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT01881126

AllerganGlaucoma, Ocular Hypertension

Start: 2013-06-30End: 2014-10-31Updated: 2015-11-30

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT02097719

AllerganGlaucoma, Ocular Hypertension

Start: 2014-05-31End: 2014-12-31Updated: 2016-01-14